Prostate Specific Antigen / Edition 2 available in Paperback
- Pub. Date:
- Health Press International
Contains 17 contributions written by urologists, biostatisticians, surgeons, and oncologists, mostly from the UK and North America, addressing the use of prostate specific antigen (PSA) in the diagnosis, treatment, and monitoring of prostate cancer patients. Covers the history of PSA, biochemistry issues, variability of immunoassays for PSA, PSA density and velocity, age-specific PSA, free and total PSA, alpha-1-antichymotrypsin complexed prostate specific antigen, early detection, repeat biopsy, staging, radical prostatectomy, radiation therapy, hormonal therapy, chemotherapy, human glandular Kallikrein 2 protection, and prostate specific membrane antigen. Illustrative tables and graphs are plentiful.
Annotation c. Book News, Inc., Portland, OR (booknews.com)
Table of Contents
The History of Prostate Specific Antigen David Crawford and Steve Waxman Biochemistry and Basic Science Ulf-Håkan Stenman Variability of Immunoassays for PSA Axel Semjonow, Gabriela De Angelis, and Hans-Peter Schmid PSA Density: Does It Still Have Utility?
David Knowles, Emilia Bagiella, and Mitchell C. Benson PSA Velocity Faiyaaz M. Jhaveri Age Specific PSA Ophelia Blake, Kevin McGeeney, and John M. Fitzpatrick Free and Total PSA Paul E. Li and Paul H. Lange Alpha-1-Antichymotrypsin Complexed Prostate Specific Antigen Michael K. Brawer PSA and Early Detection David K. Ornstein, Alfredo Velasco, and Gerald L. Andriole PSA and Repeat Biopsy Bob Djavan PSA and Staging Jonathan D. Eaton, Grenville M. Oades, and Roger S. Kirby PSA and Radical Prostatectomy Mark R. Feneley and Alan W. Partin PSA and Radiation Therapy Juanita Crook PSA and Hormonal Therapy S. Larry Goldenberg, Shane E. La Bianca, and Martin E. Gleave PSA and Chemotherapy Andrea Veatch and Celestia Higano Human Glandular Kallikrein 2 Protein George G. Klee, Charles Young, and Donald Tindall Prostate Specific Membrane Antigen Eric H. Holmes